Healthcare 21 Group (HC21) will be at MEDICA 2023 to showcase their specialist support services designed to help international medtech manufacturers navigate the UK market with confidence.
Offering sales, marketing and technical services solutions, the independent medical device distributor will be at the exhibition to present a comprehensive range of services to help manufacturers enhance sales performance, market penetration, and overall profitability in the UK.
With a track record of assisting multinational manufacturers in establishing and expanding niche product portfolios in the marketplace, HC21 offers a range of world-class services, including sales and marketing strategies, training solutions, and state-of-the-art distribution and logistics support.
Partnering with nearly 100 of the world’s leading healthcare companies, HC21 bring together a specialist sales teams with propound market knowledge and expertise across key clinical areas such as surgery, endoscopy, critical care, cardiology, and orthopaedics.
Amongst their offerings is the HC21 Academy is a centre of excellence that promotes best practices, delivers training, and showcases the latest innovations in technology.
As HC21 expands its presence in exciting new therapeutic areas, they are committed to showcasing their expertise in equipping manufacturers with the regulatory and technical know-how to strengthen their go-to-market strategy and successfully navigate the UK’s complex healthcare landscape.
Nathan Pettitt, CEO, says: “In 2023, there are key advantages to using a distributor model in the UK healthcare market. Market access, local expertise, and the removal of regulatory burdens for manufacturers and OEMs is significant.
“By partnering with the right distributor, OEMs can focus their energy on R&D and allow our specialised sales, marketing, and service teams to reach a wider range of audiences across the UK and Irish markets. We are fortunate to partner with top global medtech players such as Medtronic, Fujifilm, and 3M on selected niches across the UK and Irish markets and consistently deliver growth year on year. We are delighted to showcase to manufacturers the opportunities, benefits and added value of a partnership with Healthcare 21.”
In today’s healthcare landscape, where regulatory frameworks have grown increasingly complex and logistical hurdles have arisen due to Brexit, the role of a distributor with local knowledge is increasingly critical. HC21’s network of healthcare professionals, hospitals, and clinics provides invaluable market access opportunities for manufacturers.
The company’s understanding of the challenges and opportunities across the UK and Irish markets positions them to manage supplier portfolios efficiently and economically.
Over the past 20 years, HC21 has partnered with many of the world’s biggest and most respected medtech brands to deliver an in-direct distribution model across the UK and Irish markets, helping them drive growth and achieve quicker, more efficient routes to market.
Paul Benton, managing director, international, ABHI, said: “The healthcare landscape has changed considerably in recent years with complex regulatory frameworks and logistical hurdles as a result of Brexit. We are delighted to welcome HC21 to the ABHI UK Pavilion at MEDICA this year, where they’ll be showcasing their expert services to help manufactures across the medical technology landscape strengthen their go-to-market strategy in the UK.”
With sales of more than €180 million across 15 therapeutic segments, and more than 500 employees, HC21 is a large and respected medical device distributor. As part of its 2024 expansion programme, the company is actively seeking to connect with medtech manufacturers in search of a new distribution partner for the UK and Irish markets. HC21 has a unique position, with access to a network of similar entrepreneurial distribution businesses across Europe, as part of the AddLife Group.